Associations between gonadotropins, testosterone and beta amyloid in men at risk of Alzheimer's disease
G Verdile, SM Laws, D Henley, D Ames, AI Bush, KA Ellis, NG Faux, VB Gupta, Q-X Li, CL Masters, KE Pike, CC Rowe, C Szoeke, K Taddei, VL Villemagne, RN Martins
Molecular Psychiatry | NATURE PUBLISHING GROUP | Published : 2014
Related Projects (1)
Core funding for this study was provided by CSIRO, which was supplemented by 'in kind' contributions from study partners. This research is supported by the Science and Industry Endowment Fund. The AIBL investigators thank Richard Head of CSIRO for initiating and facilitating the AIBL collaboration. The study also received support from the National Health and Medical Research Council via the Dementia Collaborative Research Centres programme. Pfizer International has contributed financial support to assist with the analysis of blood samples and to further the AIBL research programme. The McCusker Alzheimer's Research Foundation Inc. contributed financial and in kind support to AIBL. We thank all those who took part as subjects in the study for their commitment and dedication to helping advance research into the early detection and causation of AD. The authors acknowledge the financial support of the CRC for Mental Health. The Cooperative Research Centre (CRC) programme is an Australian government initiative.